Indirect costs of sickness absence caused by mental and behavioural disorders (ICD-10: F00-F99) in Poland in the years 2012-2018
PDF

Keywords

indirect cost
sickness absence
mental disorders
mental illness

How to Cite

Kobuszewski, B. (2020). Indirect costs of sickness absence caused by mental and behavioural disorders (ICD-10: F00-F99) in Poland in the years 2012-2018. Wiedza Medyczna, 2(1), 30-38. https://doi.org/10.36553/wm.17

Abstract

Introduction: Mental health is necessary for achieving the complete health by individuals. According to WHO, it is "a state of well-being in which every individual realizes his or her own potential, can cope with the normal stresses of life, can work productively and fruitfully, and is able to make a contribution to her or his community" (2). Unfortunately, there is an increasing number of people suffering from mental disorders that can deteriorate their life quality, lead to problems with the standard functioning in the society, a drop in productivity, and can cause disabilities.

Purpose of the article: The purpose of this article was to attempt the estimation of indirect costs of sickness absence caused by mental and behavioural disorders (ICD-10: F00-F99) in Poland in the years 2012-2018.

Materials and methods: Indirect costs were estimated with the human capital approach using data on sickness absence provided by the Polish Social Insurance Institution (ZUS) and macroeconomic indicators published by the Central Statistical Office in Poland (GUS). The individual productivity loss was introduced by means of three indicators: Gross Domestic Product (GDP) per capita, Gross Domestic Product per person employed, corrected Gross Domestic Product.

Results: Estimated indirect costs of sickness absence caused by mental and behavioural disorders (ICD-10: F00-F99) in Poland in 2012 were: 1.62 billion PLN measured in terms of GDP per capita, 2.86 billion PLN measured in terms of corrected GDP per person employed, and 4.40 billion PL measured in terms of GDP per person employed. And those costs in 2018 were 2.93 billion PLN, 4.57 billion PLN, and 7.03 billion PLN respectively, and they were higher by ca. 60-80% than in 2012.

Conclusions: The described estimation of indirect costs can lead to conclusions that mental health care in Poland is quite poor - indirect costs can reach twice the level of National Health Fund (NFZ) expenses on the mental health care.

https://doi.org/10.36553/wm.17
PDF

References

(1) Constitution of the World Health Organization, Geneva 1948, http://apps.who.int/gb/bd/PDF/bd47/EN/constitution-en.pdf?ua=1. Accessed 9 October 2019.

(2) Gromulska L. Zdrowie psychiczne w świetle dokumentów Światowej Organizacji Zdrowia [Mental health in the world according to WHO documents], Przegl Epidemiol 2010, 64(1): pp. 127-132, http://www.przeglepidemiol.pzh.gov.pl/pobierz-artykul?id=1255. Accessed 9 October 2019.

(3) Report by the Commissioner for Human Rights, research guidance Lipowicz I., Mental health protection in Poland: challenges, plans, barriers, good practices Warsaw 2014, https://www.rpo.gov.pl/sites/default/files/Ochrona_zdrowia_psychicznego.pdf. Accessed 9 October 2019.

(4) Financial plan of the National Health Fund for 2012, https://www.nfz.gov.pl/gfx/nfz/userfiles/_public/bip/finanse_nfz/2012/2012_104_def_zal.xls. Accessed 9 October 2019.

(5) Amendment to the financial plan of the National Health Fund for 2013 approved by the Minister of Health in consultation with the Minister of Finance on 31 July 2013, https://www.nfz.gov.pl/gfx/nfz/userfiles/_public/bip/finanse_nfz/2013/2013_07_31_plan_2013.xls. Accessed 9 October 2019.

(6) Amendment to the financial plan of the National Health Fund for 2014 approved by the Minister of Health in consultation with the Minister of Finance on 30 December 2014, https://www.nfz.gov.pl/gfx/nfz/userfiles/_public/bip/finanse_nfz/2014/2015_01_19_zmiana_planu_2014.xls. Accessed 9 October 2019.

(7) Final financial plan of the National Health Fund for 2015, https://www.nfz.gov.pl/gfx/nfz/userfiles/_public/bip/finanse_nfz/2015/plan_ostateczny_2015_r..xls. Accessed 9 October 2019.

(8) Final financial plan of the National Health Fund for 2016, https://www.nfz.gov.pl/gfx/nfz/userfiles/_public/bip/finanse_nfz/2016/plan_ostateczny_nfz_na_2016_r..xlsx. Accessed 9 October 2019.

(9) Final financial plan of the National Health Fund for 2017, https://www.nfz.gov.pl/gfx/nfz/userfiles/_public/bip/finanse_nfz/2018/plan_ostateczny_2017.xlsx. Accessed 9 October 2019.

(10) Final financial plan of the National Health Fund for 2018, https://www.nfz.gov.pl/gfx/nfz/userfiles/_public/bip/finanse_nfz/2018/plan_ostateczny_2018.xlsx. Accessed 9 October 2019.

(11) Sickness absence in Q1-Q4 in 2012 due to own illness of people insured with ZUS by specific illness or disease, https://psz.zus.pl/documents/493365/532835/Absencja+chorobowa+wg+jednostek+chorobowych+2012.xls/93dccef4-0ee2-415d-adbb-228b0228cc01. Accessed 9 October 2019.

(12) Sickness absence in Q1-Q4 in 2013 due to own illness of people insured with ZUS by specific illness or disease, https://psz.zus.pl/documents/493365/532835/Absencja+chorobowa+wg+jednostek+chorobowych+2013.xls/84dedda7-1ce3-4f8e-891c-ca817b884df7. Accessed 9 October 2019.

(13) Sickness absence in Q1-Q4 in 2014 due to own illness of people insured with ZUS by specific illness or disease, https://psz.zus.pl/documents/493365/532835/Absencja+chorobowa+wg+jednostek+chorobowych+2014.xls/e0849757-6f08-4959-8863-91138eafae45. Accessed 9 October 2019.

(14) Sickness absence in Q1-Q4 in 2015 due to own illness of people insured with ZUS by specific illness or disease, https://psz.zus.pl/documents/493365/532835/Absencja+chorobowa+wg+jednostek+chorobowych+2015.xls/abdf3057-6c66-49a5-a226-a4458f46aa40. Accessed 9 October 2019.

(15) Sickness absence in Q1-Q4 in 2016 due to own illness of people insured with ZUS by specific illness or disease, https://psz.zus.pl/documents/493365/532835/Absencja+chorobowa+wg+jednostek+chorobowych+2016.xls/b3302fae-cb98-4889-8b45-e93eed7b71c5. Accessed 9 October 2019.

(16) Sickness absence in Q1-Q4 in 2017 due to own illness of people insured with ZUS by specific illness or disease, https://psz.zus.pl/documents/493365/532835/Absencja+chorobowa+wg+jednostek+chorobowych+2017.xls/e720b979-beee-445c-aafc-4d8a3fc42891. Accessed 9 October 2019.

(17) Sickness absence in Q1-Q4 in 2018 due to own illness of people insured with ZUS by specific illness or disease, https://psz.zus.pl/documents/493365/532835/Absencja+chorobowa+wg+jednostek+chorobowych+2018.xls/047df2db-29d7-7c21-30ec-f887b4b1c5c8. Accessed 9 October 2019.

(18) Expenditures on social insurance benefits due to incapacity for work in 2012, https://www.zus.pl/documents/10182/39540/Wydatki+na+%C5%9Bwiadczenia+z+ubezpiecze%C5%84+spo%C5%82ecznych+zwi%C4%85zane+z+niezdolno%C5%9Bci%C4%85+do+pracy+w+2012+r.pdf/3c86dfa5-ef29-4b77-a582-6e155992f118. Accessed 9 October 2019.

(19) Expenditures on social insurance benefits due to incapacity for work in 2013, https://www.zus.pl/documents/10182/39540/Wydatki+na+%C5%9Bwiadczenia+z+ubezpiecze%C5%84+spo%C5%82ecznych+zwi%C4%85zane+z+niezdolno%C5%9Bci%C4%85+do+pracy+w+2013+r.pdf/9e42abd4-56e5-4517-894c-8487e8569ef1. Accessed 9 October 2019.

(20) Expenditures on social insurance benefits due to incapacity for work in 2014, https://www.zus.pl/documents/10182/39540/Wydatki+na+%C5%9Bwiadczenia+z+ubezpiecze%C5%84+spo%C5%82ecznych+zwi%C4%85zane+z+niezdolno%C5%9Bci%C4%85+do+pracy+w+2014+r/6082d1de-6afc-4c47-8d93-1313762cebef. Accessed 9 October 2019.

(21) Expenditures on social insurance benefits due to incapacity for work in 2015, https://www.zus.pl/documents/10182/39540/Wydatki+na+%C5%9Bwiadczenia+z+ubezpiecze%C5%84+spo%C5%82ecznych+zwi%C4%85zane+z+niezdolno%C5%9Bci%C4%85+do+pracy+w+2015+r.pdf/c5e712fc-f241-45d2-85ab-54b73619e8c9.Accessed 9 October 2019.

(22) Expenditures on social insurance benefits due to incapacity for work in 2016, https://www.zus.pl/documents/10182/39540/Wydatki+na+%C5%9Bwiadczenia+z+ubezpiecze%C5%84+spo%C5%82ecznych+zwi%C4%85zane+z+niezdolno%C5%9Bci%C4%85+do+pracy+w+2016+r.pdf/e806a70c-4096-4d59-8536-421868f094f9. Accessed 9 October 2019.

(23) Expenditures on social insurance benefits due to incapacity for work in 2017, https://www.zus.pl/documents/10182/39540/Wydatki+na+%C5%9Bwiadczenia+z+ubezpiecze%C5%84+spo%C5%82ecznych+zwi%C4%85zane+z+niezdolno%C5%9Bci%C4%85+do+pracy+w+2017+r.pdf/943ee692-aa15-b09f-55ea-e263ebf9200a. Accessed 9 October 2019.

(24) Information on cash benefits from the Social Insurance Fund and other benefits from social security - Q4/Jan.-Dec. 2018, https://www.zus.pl/documents/10182/167627/Biuletyn_WOJ_K4_2018/3e549502-2692-7c36-804f-943a2845833e. Accessed 9 October 2019.

(25) EY. Methodology for measuring indirect costs in the Polish system of health protection, Warsaw 2013, https://secure.sitebees.com/file/attachment/546333/42/EY_2013.09.05_raport_Metodyka+pomiaru+kosztow+posrednich.pdf.Accessed 9 October 2019.

(26) Czajka Z.: Gospodarowanie kapitałem ludzkim [Human capital management]. Wydawnictwo Uniwersytetu w Białymstoku, Białystok 2011

(27) Hermanowski T.: Szacowanie kosztów społecznych choroby i wpływu stanu zdrowia na aktywność zawodową i wydajność pracy [Estimation of social costs of disease and health state impact on occupational activity and labour productivity]. Wydawnictwo Naukowe PWN, Warsaw 2013.

(28) ed. Gałązka-Sobotka M. Schizofrenia – analiza kosztów ekonomicznych i społecznych [Schizophrenia – analysis of economic and social costs], Instytut zarządzania w ochronie zdrowia [Health and Disease Management Institute], Warsaw 2015, https://izwoz.lazarski.pl/fileadmin/user_upload/Raport_Schizofrenia_13_04.pdf. Accessed 9 October 2019.

(29) Information on cash benefits from the Social Insurance Fund and other benefits from social security - Q4/Jan.-Dec. 2012, https://www.zus.pl/documents/10182/167627/biul0412.pdf/17bd1239-6691-424e-af22-3181cf1d8338. Accessed 9 October 2019.

(30) Information on cash benefits from the Social Insurance Fund and other benefits from social security - Q4/Jan.-Dec. 2013, https://www.zus.pl/documents/10182/167627/biul0413.pdf/dfd7c6db-50c3-4374-9b7e-5616a4c96953. Accessed 9 October 2019.

(31) Information on cash benefits from the Social Insurance Fund and other benefits from social security - Q4/Jan.-Dec. 2014, https://www.zus.pl/documents/10182/167627/biul0414.pdf/b2401b7b-8ef4-41c8-9887-f75a9e4f92d1

(32) Information on cash benefits from the Social Insurance Fund and other benefits from social security - Q4/Jan.-Dec. 2015, https://www.zus.pl/documents/10182/167627/biul0415.pdf/bcb5633a-6104-4f41-a63b-284b369f2e38. Accessed 9 October 2019.

(33) Information on cash benefits from the Social Insurance Fund and other benefits from social security - Q4/Jan.-Dec. 2016, https://www.zus.pl/documents/10182/167627/Biul0416a.pdf/1319b965-0c24-4a62-99f8-cfcb277419b4. Accessed 9 October 2019.

(34) Information on cash benefits from the Social Insurance Fund and other benefits from social security - Q4/Jan.-Dec. 2017, https://www.zus.pl/documents/10182/167627/Biul0417.pdf/9c91686e-fe4a-4401-9be6-9058c5c8654a. Accessed 9 October 2019.

(35) Central Statistical Office in Poland Poland - macroeconomic indicators. Annual economic indicators. https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultstronaopisowa/1772/1/5/roczne_wskazniki_makroekonomiczne_cz_iii.xlsx. Accessed 9 October 2019.

(36) Władysiuk M. et al. Koszty pośrednie w ocenie technologii medycznych. Metodyka, badanie pilotażowe i rekomendacje [Indirect costs in estimating medical technologies. Methodology, pilot study, and recommendations], The Employers' Union of Innovative Pharmaceutical Companies IINFARMA, Warsaw 2014, https://www.infarma.pl/assets/files/raporty/Raport_Koszty_posrednie_w_ocenie_technologii_medycznych_01.pdf. Accessed 9 October 2019.

(37) Wrona W, Hermanowski T. et al. Koszty utraconej produktywności w analizach farmakoekonomicznych. Część II. Badanie opinii w grupie ekspertów [Costs of lost productivity in pharmacoeconomic analyses. Part 2. Expert survey] , Przegl Epidemiol, 2011, 65(1):153-157, http://www.przeglepidemiol.pzh.gov.pl/pobierz-artykul?id=1362. Accessed 9 October 2019.

(38) Wrona W, Hermanowski T. et al. Koszty utraconej produktywności w analizach farmakoekonomicznych. Część I. Przegląd systematyczny piśmiennictwa [Costs of lost productivity in pharmacoeconomic analyses. Part 1. Systematic reviews] , Przegl Epidemiol, 2011, 65(1):147-162, http://www.przeglepidemiol.pzh.gov.pl/pobierz-artykul?id=1361. Accessed 9 October 2019.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.